Literature DB >> 18663564

Cellular and molecular characterisation of the hyper immunoglobulin M syndrome associated with congenital rubella infection.

Rohan Ameratunga1, See-Tarn Woon, Wikke Koopmans, John French.   

Abstract

INTRODUCTION: The hyper-immunoglobulin M syndrome (HIM) is a rare group of immune deficiency disorders characterised by normal or increased serum IgM with normal or reduced IgG, IgA and IgE.
MATERIALS AND METHODS: We have undertaken detailed cellular and molecular studies in a 53-year-old man with HIM as a result of congenital rubella.
RESULTS: No mutations were detected in the CD40 ligand, activation-induced cytidine deaminase and uracil DNA glycosylase. His T-cell responses to lectins and antigens were normal. Flow cytometry confirmed the presence of CD40 ligand on activated T cells. Most CD40-dependent functions that were tested, including B-cell proliferation, isotype switching and production of memory B cells, were normal. CD40/IL4 dependent rescue from anti-IgM-induced apoptosis was impaired.
CONCLUSION: The detection of cell-surface IgG but lack of serum IgG indicated that he may have an antibody secretion defect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663564     DOI: 10.1007/s10875-008-9219-y

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  PNEUMOCYSTIS CARINII PNEUMONIA AND CONGENITAL HYPOGAMMAGLOBULINAEMIA.

Authors:  W C MARSHALL; H J WESTON; M BODIAN
Journal:  Arch Dis Child       Date:  1964-02       Impact factor: 3.791

2.  Antibody deficiency syndrome associated with beta-2 macroglobulinemia.

Authors:  R HONG; W K SCHUBERT; E V PERRIN; C D WEST
Journal:  J Pediatr       Date:  1962-12       Impact factor: 4.406

3.  Hyper IgM with combined immunodeficiency.

Authors:  E A Goddard; E J Hughes; D W Beatty
Journal:  J Clin Lab Immunol       Date:  1991-08

4.  Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice.

Authors:  Cristina Rada; Gareth T Williams; Hilde Nilsen; Deborah E Barnes; Tomas Lindahl; Michael S Neuberger
Journal:  Curr Biol       Date:  2002-10-15       Impact factor: 10.834

5.  Improved dysgammaglobulinaemia in congenital rubella syndrome after immunoglobulin therapy: correlation with CD154 expression.

Authors:  N Kawamura; A Okamura; H Furuta; S Katow; M Yamada; I Kobayashi; M Okano; K Kobayashi; Y Sakiyama
Journal:  Eur J Pediatr       Date:  2000-10       Impact factor: 3.183

6.  The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.

Authors:  Jerry A Winkelstein; Mary C Marino; Hans Ochs; Ramsey Fuleihan; Paul R Scholl; Raif Geha; E Richard Stiehm; Mary Ellen Conley
Journal:  Medicine (Baltimore)       Date:  2003-11       Impact factor: 1.889

7.  Congenital rubella syndrome, hyper-IgM syndrome and autoimmunity in an 18-year-old girl.

Authors:  Pere Soler Palacin; Yolanda Castilla; Paula Garzón; Concepció Figueras; Joan Castellví; Teresa Español
Journal:  J Paediatr Child Health       Date:  2007-10       Impact factor: 1.954

8.  Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis.

Authors:  A Norvell; L Mandik; J G Monroe
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

9.  Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.

Authors:  Kohsuke Imai; Geir Slupphaug; Wen-I Lee; Patrick Revy; Shigeaki Nonoyama; Nadia Catalan; Leman Yel; Monique Forveille; Bodil Kavli; Hans E Krokan; Hans D Ochs; Alain Fischer; Anne Durandy
Journal:  Nat Immunol       Date:  2003-09-07       Impact factor: 25.606

10.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

View more
  3 in total

1.  Identification of germinal centres in the lymph node of a patient with hyperimmunoglobulin M syndrome associated with congenital rubella.

Authors:  Rohan Ameratunga; Chun-Jen J Chen; Wikke Koopmans; P Rod Dunbar; Maia Brewerton; Richard Lloydd; Claudia J Mansell; Chris van Vliet; See-Tarn Woon
Journal:  J Clin Immunol       Date:  2014-08-12       Impact factor: 8.317

2.  SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?

Authors:  Rohan Ameratunga; Euphemia Leung; See-Tarn Woon; Lydia Chan; Richard Steele; Klaus Lehnert; Hilary Longhurst
Journal:  J Allergy Clin Immunol Pract       Date:  2022-06-22

3.  The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review.

Authors:  Rohan Ameratunga; See-Tarn Woon; Katherine Neas; Donald R Love
Journal:  Allergy Asthma Clin Immunol       Date:  2010-06-08       Impact factor: 3.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.